5 Safe High-Yield Dividend Stocks Boomers Should Buy Before Year-End

Published November 17, 2026, 1:00pm ET · 5 min read

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

A close-up of a person's hands partially extracting a paper check from a white envelope. The check, visible against a warm wooden background, displays 'COMPANY INC.', the date 'January 10, 2013', and an amount of 'USD 10247.40', along with 'TEN THOUSANDS TWO HUNDRED AND FOURTY SEVEN 40/100 U.S. DOLLARS' written out.
An envelope revealing a check symbolizes the dividend payments insurance companies make to shareholders, often funded by investment returns from customer premiums. © AndreyPopov / iStock via Getty Images

Retirees heading into year-end need income that holds up through a recession, a rate shift or a bad quarter, so a high yield alone isn’t enough. These five US-listed payers come from five different sectors (telecom, real estate, asset management, pharma and tobacco). Each one covers its dividend from earnings or cash flow, has no cut in its recent dividend record, and keeps a balance sheet that can carry the payout. The steadiest of the group has a streak that is hard to match: in September, Realty Income announced its 116th consecutive quarterly dividend increase.

Verizon Communications: Free Cash Flow Is Rising Faster Than the Dividend

Verizon Communications (NYSE:VZ | VZ Price Prediction) yields 6.04%, and shares trade at $46.58. The quarterly dividend is $0.7075, or $2.83 a year. That annual payout uses about 56% of the low end of Verizon’s raised 2026 adjusted EPS guidance of $5.04 to $5.06[1].

Cash flow backs up the coverage. Third-quarter free cash flow came in at $7.80 billion[1], up 13.9%, on operating cash flow of $11.52 billion. Management now expects full-year free cash flow to grow by roughly 12%[1], and the company still had room for $4.0 billion of buybacks in the first nine months. The dividend record shows no recent cuts. The quarterly payout rose to $0.69 in January 2026 and to $0.7075 in April 2026, up from $0.385 in records spanning 2000 through 2003.

Bull case: The business is gaining momentum. Verizon added 406,000 postpaid phone subscribers in the third quarter, compared with 44,000 a year earlier. EBITDA margin widened from 37.8% to 40.2%, and an AWS AI infrastructure deal worth more than $2 billion gives Verizon a new source of growth. The stock’s beta of 0.26 suits a retiree who wants a calm portfolio.

Risk: Verizon carries $166.2 billion[1] of debt, and interest expense rose 17.2% year over year. Price competition in wireless could squeeze the cash flow that pays for both debt reduction and dividend growth.

Realty Income: Monthly Checks Backed by Rising AFFO

Realty Income (NYSE:O) yields 5.24% and pays every month. Its latest monthly dividend of $0.274 goes ex-dividend on November 30, 2026 and is paid on December 15, 2026. That makes it the clearest way on this list to collect income before the calendar turns. The forward annual payout of $3.288 uses about 74% of the low end of raised 2026 AFFO (adjusted funds from operations, the main cash-earnings measure for REITs) guidance of $4.45 to $4.46 per share.

Third-quarter AFFO rose 3.7% to $1.12 per share. Occupancy held at 98.8%, and renewed leases recaptured 103.5% of prior rent. Fitch rates Realty Income 'A' with a Stable outlook. The REIT also has a $5.5 billion revolving credit facility, and its equity needs are prefunded for the rest of the year. The September increase was its 136th since its 1994 NYSE listing.

Bull case: Realty Income is moving into higher-growth property types. Data centers made up 11.7% of third-quarter new investments, alongside a $6 billion hyperscale data center joint venture. The REIT put $2.6 billion to work at a 6.8% initial cash yield during the quarter.

Risk: Net debt to EBITDA stands at 7.8x, and tenants without investment-grade ratings account for 65.7% of annualized base rent. Third-quarter impairment charges of $111.6 million show that some properties are losing value.

T. Rowe Price: A Debt-Light Payer With a Year-End Ex-Date

T. Rowe Price (NASDAQ:TROW) yields 4.78%. Its quarterly dividend of $1.30 goes ex-dividend on December 16, 2026 and is paid on December 29, 2026. The forward annual payout of $5.20 uses about 53% of trailing EPS of $9.88.

The balance sheet is the main reason this pick qualifies as safe. T. Rowe Price holds $3.77 billion in cash and equivalents and $11.37 billion of shareholders’ equity, and it carries little debt. The regular quarterly dividend has risen every year since 2021: from $1.08 in 2021 to $1.20, $1.22, $1.24, $1.27 and now $1.30. The company has also paid special dividends, including $3 per share in 2021.

Bull case: Third-quarter adjusted EPS of $2.86[2] beat the $2.65 consensus. Average assets under management hit a record $1.887 trillion[2], up 9.5%, as the firm expands its ETF, SMA and model portfolio businesses.

Risk: Clients pulled a net $28.3 billion[2] in the quarter, and the effective fee rate fell to 37.8 basis points from 39.1 basis points. Wall Street is skeptical: analysts have 10 Hold ratings, 1 Sell and 3 Strong Sells on the stock, with no Buy ratings.

Pfizer: Cash Flow Covers a Payout Management Has Pledged to Protect

Pfizer (NYSE:PFE) yields 5.94% on a quarterly dividend of $0.43, or $1.72 a year. The next payment arrives on December 7, 2026. That payout uses about 58% of the low end of raised 2026 adjusted EPS guidance of $2.95 to $3.05[3].

Operating cash flow through the first nine months reached $8.8 billion[4], compared with $7.3 billion paid in dividends over the same period. Leverage ended the quarter at 2.6 times[4], below the 2.7 times target, and interest coverage is 6.5x. The dividend rose each year from $0.34 in 2018 to $0.43 in 2025 and has held there through 2026. Chief Financial Officer Cecile Guegan said Pfizer’s priorities include "maintain and, over time, grow our dividend."[4]

Bull case: Third-quarter adjusted EPS of $0.87[3] beat the $0.73 consensus. Launched and acquired products grew 32%[3], and Pfizer is on track to capture nearly all of its $7.2 billion[4] in net cost savings by the end of 2026, with another $2.5 billion planned for 2027 through 2029.

Risk: Patent expirations are coming. Pfizer expects pressure from generic competition on Ibrance and Xtandi in the US and on Eliquis internationally at the end of 2026. Paxlovid sales already fell 63%[3]. A dividend that stays flat for a second year is a realistic outcome.

Altria: 61 Increases in 57 Years and a Balance Sheet on Target

Altria (NYSE:MO) yields 5.46%. In August it raised the quarterly dividend 4.7%[5] to $1.11, which works out to $4.44[6] a year. That was the company’s 61st increase in 57 years[6]. The annual payout uses about 78% of the low end of raised 2026 adjusted EPS guidance of $5.66 to $5.74[6], which fits a management target of "mid-single-digit annual growth"[5] in the dividend.

Debt to EBITDA stood at 1.9x[5], in line with the company’s target of about 2x. In the first nine months, Altria returned $5.3 billion[5] in dividends and $735 million in buybacks, and its board added $1 billion[6] to the repurchase program. The quarterly dividend has climbed from $0.61 in 2017 to today’s level, with no regular-payment cut in the record dating back to 1999.

Bull case: Pricing power keeps profits high. The smokeable segment’s adjusted operating margin reached 64.5%[6], and income from its ABI stake jumped to $228 million from $123 million.

Risk: Altria’s adjusted domestic cigarette volumes fell about 4%[5], and Marlboro’s retail share slipped to 39.5%. The stock has also climbed 42.31% this year, so new buyers lock in less yield than holders who bought in January.

Five Sectors, One Income Plan

Together, these five stocks give a retiree income from five different industries. Each payer covers its dividend from earnings or cash flow and has no recent cut in its record. Realty Income and T. Rowe Price both have ex-dividend dates before December ends. Verizon, Pfizer and Altria add yield in the 5% to 6% range, supported by guidance each company raised this fall.

Contact [email protected] for any questions or corrections.

Lee Jackson

Lee Jackson has covered Wall Street analysts' equity and debt research and equity strategy daily for 24/7 Wall St. since 2012. His broad, diverse career, including a stint as creative services director at an NBC affiliate in Austin, Texas, gives him unique insight into the financial industry.

Lee Jackson's journey in the financial industry spans more than 30 years, including nearly two decades as an institutional equity salesperson at Bear Stearns, Lehman Brothers, and Morgan Stanley. His career spanned pivotal sell-side Wall Street events, from the dot-com rise and bubble to the Long-Term Capital Management debacle, 9/11, and the Great Recession of 2008. This reflects his resilience and adaptability amid market volatility.

Lee Jackson’s practical financial industry experience, gained through a career at some of the biggest banks and brokerage firms, is complemented by a lifetime of writing across various platforms. This unique combination allows him to shed light on the intricacies of Wall Street in a way only someone with deep insider experience and knowledge can. Moreover, his extensive network across Wall Street continues to provide direct access for him and 24/7 Wall St., a privilege few firms enjoy.

Since 2012, Jackson’s work for 24/7 Wall St. has been featured in Barron’s, Yahoo Finance, MarketWatch, Business Insider, TradingView, Real Money, The Street, Seeking Alpha, Benzinga, and other media outlets. He attended the prestigious Cranbrook Schools in Bloomfield Hills, Michigan, and has a degree in broadcasting from the Specs Howard School of Media Arts.

All articles →

Sources

  1. Verizon Form 8-K (Q3 FY2026)U.S. Securities and Exchange Commission
  2. T. Rowe Price Form 8-K (Q3 FY2026)U.S. Securities and Exchange Commission
  3. Pfizer Form 8-K (Q3 FY2026)U.S. Securities and Exchange Commission
  4. Pfizer, Inc. Q3 2026 earnings callPfizer, Inc.
  5. Altria Group, Inc. Q3 2026 earnings callAltria Group, Inc.
  6. Altria Form 8-K (Q3 FY2026)U.S. Securities and Exchange Commission